Literature DB >> 22709550

Bioeconomic modelling of raccoon rabies spread management impacts in Quebec, Canada.

S Shwiff1, C Aenishaenslin, A Ludwig, P Berthiaume, M Bigras-Poulin, K Kirkpatrick, L Lambert, D Bélanger.   

Abstract

Beginning in 2006, point infection control operations and aerial distribution of oral rabies vaccines along the US border were performed in Quebec, Canada, to control the potential spread of raccoon rabies. A benefit-cost analysis assessed the economic efficiency of this rabies control programme into the future. In this study, a mathematical simulation model was used to determine the potential spread of raccoon rabies from the 2006 index case, and incidence rates of human post-exposure prophylaxis (PEP), animal testing and human exposure investigations were calculated. Benefits were calculated as the potential savings from reduced numbers of human PEP, animal testing and human exposure investigations owing to control, which ranged from $47 million to $53 million. Programme cost scenarios were based on projections of total expenditures, which ranged from $33 million to $49 million. Economic efficiency was indicated for approximately half of the modelled scenarios, with the greatest benefit-cost ratios resulting from reduced future programme costs. © Published 2012. This article is a US Government work and is in the public domain in the USA.

Entities:  

Keywords:  benefit-cost analysis; control strategies; disease modelling; economic efficiency; rabies virus; raccoons

Mesh:

Substances:

Year:  2012        PMID: 22709550     DOI: 10.1111/j.1865-1682.2012.01351.x

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  9 in total

1.  Preparing for and responding to recent incursions of raccoon rabies variant into Canada.

Authors:  B Stevenson; J Goltz; A Massé
Journal:  Can Commun Dis Rep       Date:  2016-06-02

2.  Modelling the dispersal of the two main hosts of the raccoon rabies variant in heterogeneous environments with landscape genetics.

Authors:  Sébastien Rioux Paquette; Benoit Talbot; Dany Garant; Julien Mainguy; Fanie Pelletier
Journal:  Evol Appl       Date:  2014-05-07       Impact factor: 5.183

3.  The Economics of a Successful Raccoon Rabies Elimination Program on Long Island, New York.

Authors:  Julie L Elser; Laura L Bigler; Aaron M Anderson; Joanne L Maki; Donald H Lein; Stephanie A Shwiff
Journal:  PLoS Negl Trop Dis       Date:  2016-12-09

4.  Processes Underlying Rabies Virus Incursions across US-Canada Border as Revealed by Whole-Genome Phylogeography.

Authors:  Hannah Trewby; Susan A Nadin-Davis; Leslie A Real; Roman Biek
Journal:  Emerg Infect Dis       Date:  2017-09       Impact factor: 6.883

Review 5.  Economic evaluations of vaccines in Canada: a scoping review.

Authors:  Ellen R S Rafferty; Heather L Gagnon; Marwa Farag; Cheryl L Waldner
Journal:  Cost Eff Resour Alloc       Date:  2017-05-05

Review 6.  Management and modeling approaches for controlling raccoon rabies: The road to elimination.

Authors:  Stacey A Elmore; Richard B Chipman; Dennis Slate; Kathryn P Huyvaert; Kurt C VerCauteren; Amy T Gilbert
Journal:  PLoS Negl Trop Dis       Date:  2017-03-16

Review 7.  Rabies Elimination: Is It Feasible without Considering Wildlife?

Authors:  Krishna Prasad Acharya; Rakesh Chand; Falk Huettmann; Tirth Raj Ghimire
Journal:  J Trop Med       Date:  2022-06-26

Review 8.  Potential economic benefits of eliminating canine rabies.

Authors:  Stephanie Shwiff; Katie Hampson; Aaron Anderson
Journal:  Antiviral Res       Date:  2013-03-13       Impact factor: 5.970

Review 9.  Quantitative Outcomes of a One Health approach to Study Global Health Challenges.

Authors:  Laura C Falzon; Isabel Lechner; Ilias Chantziaras; Lucie Collineau; Aurélie Courcoul; Maria-Eleni Filippitzi; Riikka Laukkanen-Ninios; Carole Peroz; Jorge Pinto Ferreira; Merel Postma; Pia G Prestmo; Clare J Phythian; Eleonora Sarno; Gerty Vanantwerpen; Timothée Vergne; Douglas J C Grindlay; Marnie L Brennan
Journal:  Ecohealth       Date:  2018-01-12       Impact factor: 3.184

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.